DexCom, Inc. (BIT:1DXCM)

Italy flag Italy · Delayed Price · Currency is EUR
74.64
-0.17 (-0.23%)
At close: May 23, 2025
21.21%
Market Cap 30.20B
Revenue (ttm) 3.84B
Net Income (ttm) 495.17M
Shares Out n/a
EPS (ttm) 1.23
PE Ratio 60.98
Forward PE 38.94
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 74.81
Day's Range n/a
52-Week Range 61.58 - 77.61
Beta n/a
RSI 80.15
Earnings Date Jul 24, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 10,300
Stock Exchange Borsa Italiana
Ticker Symbol 1DXCM
Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD Financial Statements

News

There is no news available yet.